top of page

CONDITIONS • WESTMINSTER, ARVADA, BROOMFIELD, THORTON & DENVER METRO

PMOS / PCOS Treatment in Westminster, CO

PMOS has finally been given a name that tells the truth about what it actually is: a complex, whole-body hormonal and metabolic condition — not a problem with cysts on your ovaries.

One in eight women lives with PMOS, and an estimated 70 percent remain undiagnosed. Of those who do receive a diagnosis, most are offered the pill, metformin, and advice to lose weight — and sent home without a genuine explanation of what is happening, why it is happening, or what a truly comprehensive treatment plan would look like. There is far more available than that. And naturopathic medicine is uniquely positioned to provide it.

Same-Day & Same-Week Appointments Available

WHY THE NAME CHANGED — AND WHY IT MATTERS FOR YOUR CARE

What the old name got wrong

The name "polycystic ovary syndrome" focused attention on the ovaries and on structures that look like cysts on an ultrasound but are not actually cysts at all. They are follicles — normal structures that every woman has. This misdirection meant that for decades, women were told they had a problem with their ovaries, were given contraceptive pills to suppress their cycles, and were left without any understanding of or treatment for the real condition.

The old name also contributed to delayed diagnosis, because women without ultrasound findings of multiple follicles were told they could not have the condition, even when every other feature was present.

What PMOS finally tells us

Poly-endocrine acknowledges that the condition involves multiple hormonal systems simultaneously, not just the ovaries. Androgens, insulin, cortisol, thyroid, and other endocrine signals are all involved.

Metabolic recognizes that insulin resistance and cardiometabolic dysfunction are central to the condition, not secondary features. For many women, metabolic dysfunction is the primary driver of every symptom they experience.

Ovarian syndrome keeps the connection to reproductive health while framing the ovarian manifestations as downstream consequences of the endocrine and metabolic picture rather than the primary cause.

WE UNDERSTAND WHAT YOU'RE GOING THROUGH

You have been told your hormones are "a bit off." You have been put on the pill. And you still feel exactly the same.

The diagnosis of PCOS — now PMOS — often comes with a sense of relief followed quickly by disappointment. Relief that there is a name for what you have been experiencing. Disappointment that the treatment offered does not seem to address any of it in a meaningful way. The weight that accumulates around your middle no matter how carefully you eat. The hair that grows on your face and chin while it thins on your head. The periods that are irregular, painful, or absent for months at a time. The skin that breaks out like it did in adolescence. The exhaustion that does not lift. The anxiety and mood swings that no one seems to connect to your hormones. The difficulty getting pregnant, or the fear of what it will take. And perhaps the most damaging thing of all: the years of being told that the way to address all of this is to lose weight, as though the weight gain were a choice rather than a hormonal consequence of the condition itself. PMOS is not a lifestyle disease. It is a complex endocrine and metabolic condition with specific, identifiable, treatable mechanisms. Understanding those mechanisms is where real care begins.

THE WIDE RANGE OF PMOS SYMPTOMS

  • Irregular, absent, or very heavy menstrual cycles

  • Excess hair growth on the face, chest, or abdomen (hirsutism) and hair thinning on the scalp

  • Persistent acne, especially along the jaw and chin

  • Weight gain that is disproportionately distributed around the abdomen and resistant to standard dietary approaches

  • Fatigue, brain fog, and energy crashes, particularly after eating carbohydrates

  • Difficulty conceiving or a history of recurrent early miscarriage

  • Anxiety, depression, and mood instability with a hormonal pattern

  • Dark skin patches, particularly in skin folds — a sign of significant insulin resistance

THE CONNECTION TO PAIN

PMOS has direct musculoskeletal consequences that most women are never told about. The insulin resistance central to PMOS accelerates tendon degeneration, drives joint inflammation, and impairs the body's tissue repair capacity. Women with PMOS are significantly more likely to develop frozen shoulder, Achilles tendinopathy, and plantar fasciitis — all connected to the hormonal and metabolic environment the condition creates.

If you have PMOS and a pain condition that is not resolving, the metabolic picture underlying your PMOS may be one of the most important things to address for both your hormonal and your musculoskeletal health.

WHAT YOU PROBABLY HAVEN'T BEEN TOLD

PMOS is not primarily a reproductive condition. It is a metabolic and endocrine condition whose primary driver, in most cases, is insulin resistance — and treating it without addressing insulin resistance is treating the smoke while the fire continues.

HOW PMOS ACTUALLY WORKS — AND WHY THE PILL DOES NOT FIX IT

In the majority of PMOS cases, the root mechanism is insulin resistance. When cells become resistant to insulin, the pancreas compensates by producing more of it. Elevated insulin then signals the ovaries to produce excess androgens — the hormones responsible for the hair growth, acne, and irregular cycles that characterize the condition. The elevated androgens disrupt the normal hormonal signaling that drives ovulation, leading to the irregular or absent cycles and reduced fertility. The elevated insulin simultaneously drives fat storage, particularly in the abdomen, and creates the carbohydrate cravings and energy crashes that make standard calorie-restriction approaches so difficult to sustain. Every symptom of PMOS can be traced back, at least partially, to this central insulin resistance. It is the engine of the condition.

The oral contraceptive pill, which is the most commonly prescribed first-line treatment for PMOS, does not address insulin resistance. It suppresses the hormonal cycle artificially, masking the irregular periods and providing some symptom relief for acne and excess hair growth. But it does nothing for the underlying metabolic dysfunction — and in some women it worsens insulin resistance. When the pill is stopped, the condition returns exactly as it was because nothing that produced it has changed. This is not a failure of the woman. It is a predictable consequence of treating a metabolic condition with a hormonal override rather than addressing the metabolic mechanism directly.

The androgen excess picture — beyond hair and acne

Elevated androgens in PMOS are responsible for far more than the cosmetically distressing symptoms that are usually the focus. Androgens disrupt sleep quality, impair mood regulation, and contribute to the anxiety that is highly prevalent in PMOS. They alter the gut microbiome in ways that worsen insulin resistance and systemic inflammation. They affect cardiovascular risk through their impact on lipid profiles and blood vessel function. And they have a significant impact on mental health: PMOS carries a substantially elevated rate of anxiety, depression, and eating disorders compared to the general population, driven partly by the androgen and insulin environment and partly by the experience of a condition that affects appearance, fertility, and energy simultaneously. Treating androgen excess through mechanisms that address its root cause — insulin resistance and inflammatory drivers — produces improvement across all of these domains simultaneously.

The mental health burden of PMOS is consistently underestimated in clinical settings. It is not separate from the hormonal picture — it is a direct consequence of it.

PMOS and long-term health risks that standard care rarely addresses

PMOS is a lifelong metabolic condition with consequences that extend well beyond reproductive years. Women with PMOS have substantially elevated lifetime risk of type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and endometrial cancer from chronic anovulatory cycles producing unopposed estrogen. These are not minor risks. They are among the most significant preventable health outcomes in women's medicine. Yet the clinical follow-up most PMOS patients receive focuses almost entirely on cycle regulation and fertility, with metabolic monitoring and risk reduction receiving minimal attention. A naturopathic approach to PMOS is inherently a long-term metabolic protection strategy — because reversing insulin resistance reduces the risk of every one of these downstream outcomes simultaneously.

Women with PMOS who do not address the underlying insulin resistance have a seven-fold elevated lifetime risk of type 2 diabetes compared to women without the condition.

The gut, inflammation, and PMOS

Research increasingly shows that gut dysbiosis — an imbalance in the gut microbiome — is both a driver and a consequence of PMOS. Women with PMOS have measurably different microbiome compositions compared to metabolically healthy women, with reduced diversity and an excess of inflammatory bacterial species. These inflammatory bacteria produce compounds that worsen insulin resistance, increase androgen production, and drive systemic inflammation. This creates a reinforcing cycle: PMOS worsens gut dysbiosis, and gut dysbiosis worsens PMOS. Breaking this cycle through gut health restoration is one of the most important and most underutilized interventions available. Gut health is not a peripheral consideration in PMOS management. It is central to the metabolic environment that determines the severity and trajectory of the condition.

Studies have demonstrated that targeted probiotic interventions in PMOS produce measurable improvements in insulin resistance, androgen levels, and inflammatory markers — independent of dietary changes.

OUR APPROACH

Conventional care versus our approach

We fully support and work collaboratively with the patient's gynecologist or endocrinologist. Medication is appropriate in certain presentations and stages of PMOS management, particularly for ovulation induction and metabolic support. Our naturopathic approach provides the comprehensive metabolic assessment and targeted treatment that standard PMOS care consistently fails to deliver.

The conventional approach

What most patients experience

  1. Diagnosis made on the basis of irregular cycles, androgen excess, and/or ultrasound findings — often delayed by years due to clinical confusion from the old name

  2. Oral contraceptive pill prescribed for cycle regulation and androgen-related symptoms

  3. Metformin added if there is clinical insulin resistance or if the patient is trying to conceive

  4. Advice to lose weight and exercise — without acknowledgment that the PMOS itself is making both significantly harder

  5. Gut health, thyroid function, adrenal androgens, nutritional contributors, and systemic inflammation rarely assessed as part of the management plan

  6. Long-term metabolic risk reduction and musculoskeletal consequences of insulin resistance not addressed

Standard PMOS care manages symptoms with hormonal suppression. Its limitation is that it does not address the metabolic and endocrine root causes that the new name — polyendocrine metabolic ovarian syndrome — was specifically chosen to highlight.

What we do differently

  1. Comprehensive hormonal and metabolic assessment: fasting insulin and HOMA-IR, full androgen panel, complete thyroid panel, adrenal androgen assessment (DHEA-S), inflammatory markers, gut health, and nutritional status

  2. Insulin resistance as the primary treatment target: specific carbohydrate quality guidance, meal timing, and therapeutic interventions with documented insulin-sensitizing effects — berberine, magnesium, inositol, and alpha-lipoic acid — each with clinical evidence in PMOS specifically

  3. Gut microbiome restoration: targeted probiotic and prebiotic protocols addressing the specific dysbiosis pattern associated with PMOS, reducing the gut-driven inflammation and androgen production that worsen the hormonal picture

  4. Adrenal androgen assessment and management: identifying the proportion of androgen excess that originates in the adrenal glands rather than the ovaries — a distinction that changes the treatment approach and is rarely made in standard care

  5. Thyroid optimization: PMOS and thyroid dysfunction are closely associated, each worsening the other. A complete thyroid panel including antibodies identifies this frequently coexisting condition whose treatment has direct benefits for the PMOS metabolic picture

  6. Musculoskeletal integration: for patients with pain conditions alongside PMOS, addressing the insulin resistance and systemic inflammation driving both as a unified treatment target — improving hormonal health and pain outcomes simultaneously

We work in full collaboration with the patient's gynecologist and endocrinologist. We do not alter prescribed medications. Our role is the metabolic, nutritional, and systems-level care that PMOS demands and that standard management has historically failed to provide.

WHAT MAKES OUR APPROACH DIFFERENT — IN A SINGLE PARAGRAPH

Standard PMOS care manages symptoms with the pill and metformin. Our approach targets the insulin resistance, gut dysbiosis, adrenal contribution, and nutritional deficiencies that are generating those symptoms in the first place. This is precisely what the new name PMOS was designed to call attention to: the polyendocrine and metabolic nature of this condition demands a polyendocrine and metabolic treatment approach. We provide that approach. We address the insulin resistance that is the central engine of the condition, the gut environment that is amplifying it, the adrenal and thyroid co-contributors that standard testing rarely identifies, and the downstream musculoskeletal consequences that affect many women with PMOS and that are inseparable from the same metabolic picture driving their hormonal symptoms. The PMOS name changed to reflect what practitioners like ours have been doing for years: treating the whole condition, not just the easiest-to-measure symptom.

KEY NATUROPATHIC INTERVENTIONS WITH STRONG PMOS EVIDENCE

These interventions have specific clinical evidence in PMOS — and are almost never offered as part of standard care

Inositol

Myo-inositol and D-chiro-inositol are naturally occurring compounds that act as second messengers in insulin signaling pathways. Multiple clinical trials have demonstrated that supplementation improves insulin sensitivity, reduces androgen levels, restores regular menstrual cycles, and improves egg quality in women with PMOS. In some studies, inositol produces outcomes comparable to metformin with a superior safety profile. It is one of the best-supported natural interventions in all of reproductive endocrinology, and it is almost never mentioned in a standard PMOS appointment.

Berberine

Berberine is a plant-derived compound with insulin-sensitizing effects that work through similar pathways to metformin. Clinical trials specifically in PMOS have demonstrated reductions in fasting insulin, improvements in androgen profiles, and restored ovulation rates comparable to metformin. Berberine also favorably modifies the gut microbiome, addressing two of PMOS's primary drivers simultaneously. For patients who cannot tolerate metformin or who want a natural alternative with comparable evidence, berberine is a clinically meaningful option.

IR Sauna and insulin sensitivity

Infrared sauna therapy improves insulin sensitivity through multiple mechanisms: activating heat shock proteins that enhance glucose uptake, reducing the systemic inflammation that maintains insulin resistance, and improving the autonomic nervous system balance that regulates metabolic function. For women with PMOS whose insulin resistance is a barrier to both metabolic improvement and physical activity tolerance, sauna therapy provides a meaningful metabolic intervention during the period when exercise capacity and dietary changes are being established. It also supports the adrenal regulation and stress management that are particularly relevant in adrenal-predominant PMOS.

TAKE THE NEXT STEP

PMOS finally has a name that describes the whole condition. Your treatment should address it the same way.

Comprehensive metabolic and hormonal assessment, insulin resistance management, gut health, and integrated pain care — all under one roof.

Not sure where to begin? Give us a call and we'll help you choose the best first step.

Location
8120 Sheridan Blvd
C217
Arvada, CO 80003

Business Hours
Sunday: Closed
Monday: Closed
Tuesday: 9:00 am - 6:00 pm
Wednesday: 9:00 am - 6:00 pm
Thursday: 9:00 am - 6:00 pm
Friday: 9:00 am - 6:00 pm
Saturday: 9:00 am - 1:00 pm

Screenshot 2025-01-30 at 3.11.06 PM.png
©2026 by True Health Centers

Serving
Westminster, Arvada, Broomfield, Thorton, Denver Metro

bottom of page